CAR-T cell therapy in plain language, from collection day to the months after
What CAR-T cell therapy is, what happens from cell collection to infusion and recovery, its main side effects, costs, and where trials are heading next.
Every explainer and research read we have published, newest first: stem cells and tissue repair, how biotech medicines are made and tested, clinical trials, careers and the business side of the life sciences. 46 pieces so far.
What CAR-T cell therapy is, what happens from cell collection to infusion and recovery, its main side effects, costs, and where trials are heading next.
What organoids are, how they are grown, what gut, brain, kidney and tumor organoids are used for, where they fall short and how the rules are changing.
How four genes turned adult cells into pluripotent stem cells, what iPSCs are used for, the first patients treated and the safety questions still open.
Phase 2 is where most experimental drugs stop. The numbers behind that, the main reasons, and what they mean when you read trial news.
How skin ages from the inside and the outside, and how strong the evidence really is for sunscreen, retinoids, vitamin C, lifestyle and stem cell creams.
What unproven stem cell clinics sell, the harms and FDA actions on record, plus warning signs and questions to ask before paying for a treatment.
A composite shift in a GMP cell therapy facility, from gowning at dawn to handover at dusk, plus who works there and how they got the job.
A section by section guide to ClinicalTrials.gov records: status, phase, design, outcomes, eligibility, results, and the signs of a pay-to-participate listing.
A pill comes off a production line by the million. Many cell therapies are made one patient at a time. Here is every step from collection to infusion.
Stem cells are defined by what they do, not by how they look. A plain guide to self-renewal, potency, niches and blood stem cells.